Two dietary recommendations effective measures for reducing risk of obesity-related cancers
the ONA take:
A study from New York University (NYU) sought to evaluate whether the diet and physical activity guidelines for preventing cancer are in fact associated with a reduced risk of obesity-related cancers and the most common site-specific cancers (breast, prostate, and colorectal cancers).
The researchers analyzed medical and dietary data for 2,983 men and women who participated in the Framingham Heart Study, a 60-year population study that tracked factors related to cardiovascular disease as well as cancer.
Using a seven-point score based on recommendations for body fat, physical activity, foods that promote weight gain, plant foods, animal foods, alcohol consumption, and food preparation and processing, the researchers found that overall concordance to the guidelines was not associated with obesity-related cancer risk.
However, when score components were evaluated individually, the researchers found that two components, plant foods and alcohol consumption, were strong predictors of cancer risk.
The researchers suggest, based on the study’s results, that dietary advice on preventing cancer should emphasize the importance of eating a plant-based diet and restricting alcohol consumption.
Whether diet and physical activity guidelines for preventing cancer are in fact associated with reduced risk of obesity-related cancers.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|